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Purpose
The purpose of the study was to evaluate
the usefulness of the cytokines-block
micronucleus (MN) assay in assessment of
radiosensitivity of lymphocytes in cancer patients.
Material and Method
Lymphocytes from 16 cervical cancer
patients, 23 head & neck (H&N) cancer patients,
7 lung cancer patients and 20 healtly donors were
analysed using micronucleus assay. Blood
samples from the patients were taken before
radiotherapy. Lymphocytes were irradiated in
vitro with60 Co gamma rays in doses 1, 2, 3 and 4
Gy. The proportion of binucleated cell (BC) and
the micronuclei (MN) frequency in BC only were
counted.
Results
The proportion of BC in cancer patients
ranged from 20 to 55% and was similar in the
control group. MN frequency assessed 5 times
over 6 months in 4 healthy donors showed that
the inter-individual variation was significantly
higher than intra-individual. Before (0 Gy) and
after irradiation (1-4 Gy) no statistical
differences in the mean number of MN/BC were
observed between healthy donors and cancer
patients group, however the highest values were
found in lung cancer patients. Nevertheles,
statistical cluster analysis allowed to divide each
group of donors into radioresistans and
radiosensitive subgroups of patients. They
showed significantly different (p<0.05) dose-
response relationship. Separate comparison of
the mean MN frequency within all examined
radioresistant and radiosensitive subgroups,
showed statisticaly significant differences only
after a dose of 4 Gy. At this dose, the lung cancer
patients from radioresistant subgroups presented
significantly lower radioresistance (p<0.05) than
the other SUbgroups, that is control, cervical and
H&N cancer patients groups. Within
radiosensitive SUbgroups, lung cancer patients as
well as cervical cancer patients show significantly
(p<0.05) higher MN frequency in comparison to
control and H&N cancer patients.
Conclusion
This work has shown that the MN assay
performed on lymphocytes can show differences
in the intrinsic radiosensitivity of cancer patients
and healthy donors.
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Our work shows measurments of depth
dose function and beam profiles dependance
on field's contour and size shaped by the
multi leaf collimator.
All measurements were done for linear
accelerator Clinac 2300 - Varian. Such obtained
values were compared with analogical ones for
Rep. Praet. Oneal. 2 (2) 1997
square fields. Dose distributions across the
beam for multileaf collimator and for individual
blocks were analized.
Work load needed for clinical dosimetry
of multileaf collimator was estimated.
Proposols for measurment protocol in clinical
dosimetry is shown.
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